These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14729627)

  • 1. HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.
    Herrmann F; Lehr HA; Drexler I; Sutter G; Hengstler J; Wollscheid U; Seliger B
    Cancer Res; 2004 Jan; 64(1):215-20. PubMed ID: 14729627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.
    Bukur J; Herrmann F; Handke D; Recktenwald C; Seliger B
    J Biol Chem; 2010 Oct; 285(40):30419-26. PubMed ID: 20663889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
    Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
    Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.
    Seliger B; Wollscheid U; Momburg F; Blankenstein T; Huber C
    Tissue Antigens; 2000 Oct; 56(4):327-36. PubMed ID: 11098932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.
    Milano F; Guarriera M; Rygiel AM; Krishnadath KK
    PLoS One; 2010 Aug; 5(8):e12424. PubMed ID: 20865050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
    Subbarayan K; Leisz S; Wickenhauser C; Bethmann D; Massa C; Steven A; Seliger B
    Oncoimmunology; 2018; 7(4):e1373233. PubMed ID: 29632715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant Disease.
    Seliger B; Ferrone S
    Methods Mol Biol; 2020; 2055():325-350. PubMed ID: 31502159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.
    Yu Y; Pilgrim P; Zhou W; Gagliano N; Frezza EE; Jenkins M; Weidanz JA; Lustgarten J; Cannon M; Bumm K; Cobos E; Kast WM; Chiriva-Internati M
    Viral Immunol; 2008 Dec; 21(4):435-42. PubMed ID: 19115932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.
    Norell H; Carlsten M; Ohlum T; Malmberg KJ; Masucci G; Schedvins K; Altermann W; Handke D; Atkins D; Seliger B; Kiessling R
    Cancer Res; 2006 Jun; 66(12):6387-94. PubMed ID: 16778217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
    Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.
    Seliger B; Schreiber K; Delp K; Meissner M; Hammers S; Reichert T; Pawlischko K; Tampé R; Huber C
    Tissue Antigens; 2001 Jan; 57(1):39-45. PubMed ID: 11169257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.
    Mimura K; Ando T; Poschke I; Mougiakakos D; Johansson CC; Ichikawa J; Okita R; Nishimura MI; Handke D; Krug N; Choudhury A; Seliger B; Kiessling R
    Int J Cancer; 2011 Jan; 128(2):390-401. PubMed ID: 20715101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.